• Genetix turns profitable after acquiring bluebird bio assets from financial distress The Business Journals Thu, 09 Jul 2026 09:16:00 GMT
• bluebird bio balances gene therapy progress and funding needs AD HOC NEWS Tue, 07 Jul 2026 16:15:24 GMT
• a year after distressed buyout, what’s become of somerville’s bluebird bio? The Boston Globe Thu, 02 Jul 2026 14:13:00 GMT
• Car T Cell Therapy For Multiple Myeloma Pipeline 2026: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | B... Barchart.com Wed, 01 Jul 2026 15:26:16 GMT
• bluebird bio (blue) 2024 wells fargo healthcare conference summary Quartr Wed, 24 Jun 2026 08:09:10 GMT
• bio 2026: cell and gene therapy sector must break the mold to thrive BioSpace Mon, 22 Jun 2026 04:54:43 GMT
• bluebird bio inc (blue) technical analysis: support, resistance, indicators & moving averages TradingKey Sun, 21 Jun 2026 14:47:56 GMT
• bluebird bio Stock - Long-term gene therapy bet after Zynteglo and Lyfgenia setbacks AD HOC NEWS Sat, 20 Jun 2026 07:00:00 GMT
• bluebird bio inc (blue) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Thu, 18 Jun 2026 02:58:53 GMT
• bluebird bio inc (blue) dividends & stock splits: historical payouts and event timeline TradingKey Thu, 18 Jun 2026 02:23:45 GMT
• bluebird bio Inc (BLUE) Risk Assessment: Volatility, Financial Risk & Investment Risk TradingKey Wed, 17 Jun 2026 11:22:42 GMT
• bluebird bio inc (blue) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 11:21:38 GMT
• bluebird bio inc (blue) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 11:21:07 GMT
• bluebird bio inc (blue) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 11:20:46 GMT
• bluebird bio inc (blue) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 11:20:12 GMT
• bluebird bio stock (us0955031005): gene therapy hopes after zynteglo launch but funding worries ling AD HOC NEWS Thu, 21 May 2026 03:10:50 GMT
• bluebird bio inc stock (us0955031005): fda gene therapies and cash outlook back in focus AD HOC NEWS Sat, 16 May 2026 07:00:00 GMT
• future of cell and gene therapy market 2026 | market is set to reach openPR.com Fri, 15 May 2026 09:57:41 GMT
• bluebird bio stock (us0955031005): delisting pending amid restructuring AD HOC NEWS Thu, 14 May 2026 07:00:00 GMT
• sickle cell disease treatment market to reach usd 9.97 billion openPR.com Thu, 14 May 2026 06:16:28 GMT
• bluebird bio (blue) short interest & short float | updated may 2026 $blue MarketBeat Tue, 12 May 2026 15:17:47 GMT
• global hemoglobinopathy market to surpass usd 21.7 billion openPR.com Mon, 11 May 2026 12:51:04 GMT
• beta thalassemia market to reach usd 1,038.73 million by 2033 openPR.com Fri, 08 May 2026 10:52:19 GMT
• bluebird bio inc stock (us0955031005): gene therapy developer trades near 52-week low on thin volume AD HOC NEWS Fri, 08 May 2026 07:00:00 GMT
• car-t cell therapy market is registering a robust cagr of 17.5% openPR.com Thu, 30 Apr 2026 07:00:00 GMT
• carlyle, sk capital partners disclose expected closing date of bluebird bio deal MSN Mon, 27 Apr 2026 01:27:12 GMT
• carlyle, sk capital partners disclose expected closing date of bluebird bio deal MSN Sun, 26 Apr 2026 22:45:22 GMT
• track-and-trace and serialization for drug market hits new high openPR.com Fri, 24 Apr 2026 15:15:47 GMT
• gene transplant market is going to boom | novartis • gilead sciences • kite pharma • bluebird bio openPR.com Fri, 17 Apr 2026 09:43:07 GMT
• sentiment watch: is bluebird bio inc stock trending bullish - entry point & reliable intraday trade alerts baoquankhu1.vn Fri, 10 Apr 2026 12:58:12 GMT
• is this biotech stock your best shot at building a millionaire-making position? The Motley Fool Tue, 07 Apr 2026 07:00:00 GMT
• ipsc therapy market booming with rapid growth through 2033 | fate therapeutics • bluebird bio • celyad openPR.com Fri, 03 Apr 2026 06:49:39 GMT
• amani therapeutics: $25 million raised to advance neuropsychiatric therapy am-01 Pulse 2.0 Mon, 30 Mar 2026 07:00:00 GMT
• breakthrough sickle cell gene therapy a distant hope in africa Medical Brief Wed, 11 Mar 2026 15:00:19 GMT
• hemoglobinopathies market is going to boom |• novartis • pfizer • bluebird bio openPR.com Tue, 10 Mar 2026 07:00:00 GMT
• brief—lonza and genetix biotherapeutics extend deal The Pharma Letter Mon, 09 Mar 2026 18:59:57 GMT
• is bluebird bio inc. stock supported by strong cash flows - weekly stock analysis & free risk controlled daily trade plans Naître et grandir Sat, 07 Mar 2026 20:37:29 GMT
• Lilly plucks Flagship, bluebird vet for regenerative medicine unit; Novo's new China president Endpoints News Fri, 06 Mar 2026 08:00:00 GMT
• genetix touts profitability, plans major gene therapy expansion BriefGlance Mon, 02 Mar 2026 08:00:00 GMT
• sickle cell gene therapies casgevy and lyfgenia still lacking traction 2 years in BioSpace Mon, 23 Feb 2026 08:00:00 GMT
• buyout rumor: whats bluebird bio incs historical return - 2025 biggest moves & entry point strategy guides baoquankhu1.vn Thu, 19 Feb 2026 01:27:15 GMT
• gene therapy market set for explosive growth to us$ 35.91 billion openPR.com Tue, 17 Feb 2026 06:49:05 GMT
• gene therapy for rare disease market to reach us$ 24.54 billion openPR.com Tue, 17 Feb 2026 06:13:22 GMT
• is bluebird bio inc. stock positioned well for digital economy - 2025 trading recap & daily oversold stock bounce ideas mfd.ru Sun, 15 Feb 2026 01:18:52 GMT
• is bluebird bio inc. stock positioned well for digital economy - 2025 biggest moves & advanced swing trade entry alerts mfd.ru Sat, 14 Feb 2026 11:15:18 GMT
• investment review: what is the moat score of bluebird bio inc. - 2025 technical patterns & daily growth stock tips mfd.ru Thu, 12 Feb 2026 15:29:43 GMT
• ocugen appoints new finance chief to steer gene therapy pipeline toward approval AD HOC NEWS Thu, 12 Feb 2026 09:21:04 GMT
• ocugen appoints rita johnson-greene to chief financial officer citybiz Mon, 09 Feb 2026 08:00:00 GMT
• the truth about bluebird bio inc (blue): tiny stock, huge drama – is this biotech comeback real or Ad-hoc-news.de Thu, 05 Feb 2026 08:00:00 GMT
• once high-flying bluebird bio sells itself to private equity after tough times for the gene therapy maker MSN Wed, 28 Jan 2026 19:48:41 GMT
• startup altido therapeutics pursues car-t for glioblastoma tumors statnews.com Wed, 28 Jan 2026 08:00:00 GMT
• medicaid tries new approach with sickle cell: companies get paid only if costly gene therapies work Medical Marketing and Media Mon, 26 Jan 2026 15:01:09 GMT
• car t cell therapy for multiple myeloma pipeline 2025: fda approvals and clinical trials landscape with moa and roa highlights by ... Barchart.com Mon, 26 Jan 2026 08:00:00 GMT
• cell and gene therapy market innovations and key players: amgen openPR.com Wed, 21 Jan 2026 15:13:35 GMT
• medicaid tries new approach with sickle cell: companies get paid only if costly gene therapies work KFF Health News Wed, 21 Jan 2026 08:00:00 GMT
• travel stocks: what is the moat score of bluebird bio inc - july 2025 spike watch & free weekly chart analysis and trade guides baoquankhu1.vn Wed, 21 Jan 2026 01:52:36 GMT
• forecast cut: what margin trends mean for bluebird bio inc stock - exit point & fast moving stock watchlists Bộ Nội Vụ Wed, 14 Jan 2026 02:20:51 GMT
• sickle cell disease treatment market is thriving worldwide | openPR.com Tue, 13 Jan 2026 11:53:20 GMT
• gene therapy market to reach us$ 35.91 billion by 2033 | cagr 23.1% openPR.com Fri, 09 Jan 2026 12:29:42 GMT
• bluebird bio confirms ayrmid has not delivered binding offer, shares dive 9% MSN Fri, 09 Jan 2026 02:48:07 GMT
• with wings clipped by fda delay, bluebird's future is in doubt The Pharma Letter Thu, 08 Jan 2026 12:18:51 GMT
• icer publishes final findings on bluebird bio's beti-cel The Pharma Letter Thu, 08 Jan 2026 11:56:25 GMT
• positive β-thalassemia results provide rare cheer for bluebird The Pharma Letter Thu, 08 Jan 2026 09:11:13 GMT
• Taming the Complexity of CGT Commercialization: 5 Keys to a Workable Operating Model Pharmaceutical Executive Wed, 07 Jan 2026 08:00:00 GMT
• former 2seventy bio ceo starts new boston biotech with $50m The Business Journals Wed, 07 Jan 2026 08:00:00 GMT
• 50 cell and gene therapy leaders to watch in 2026 drugdiscoverytrends.com Tue, 06 Jan 2026 08:00:00 GMT
• gene therapy market is going to boom worldwide | glaxosmithkline openPR.com Mon, 05 Jan 2026 06:16:10 GMT
• why bluebird bio inc. stock is trending among retail traders - analyst upgrades & the smart money is buying these picks bollywoodhelpline.com Tue, 30 Dec 2025 00:08:43 GMT
• why bluebird bio inc. stock is trending among retail traders - stock screening results & build wealth brick by brick with us bollywoodhelpline.com Sun, 28 Dec 2025 05:37:07 GMT
• carlyle group, sk capital secure all regulatory approvals to acquire bluebird bio MSN Sat, 27 Dec 2025 16:07:00 GMT
• why bluebird bio inc. stock is trending among retail traders - cup and handle formations & reinvest for maximum compounding return... bollywoodhelpline.com Fri, 26 Dec 2025 06:09:09 GMT
• why bluebird bio inc. stock is trending among retail traders - price-to-earnings ratio insights & outstanding portfolio tips Bollywood Helpline Wed, 24 Dec 2025 00:15:17 GMT
• why bluebird bio inc. stock is trending among retail traders - fed meeting & free community supported trade ideas Улправда Sat, 20 Dec 2025 16:23:20 GMT
• why bluebird bio inc. stock is trending among retail traders - 2025 market overview & smart swing trading alerts Улправда Fri, 19 Dec 2025 21:50:29 GMT
• why bluebird bio inc. stock could see breakout soon - 2025 market wrapup & fast gain swing trade alerts DonanımHaber Fri, 19 Dec 2025 12:44:48 GMT
• is bluebird bio inc. stock undervalued vs historical averages - trade entry report & community supported trade ideas Улправда Fri, 19 Dec 2025 09:59:50 GMT
• what technical charts say about bluebird bio inc. stock - portfolio value report & verified momentum stock watchlist Улправда Fri, 19 Dec 2025 07:35:51 GMT
• why bluebird bio inc. stock is trending among retail traders - small cap stock opportunities & investment recommendations you can ... bollywoodhelpline.com Wed, 17 Dec 2025 17:12:52 GMT
• trio of us biotech companies appoint legal chiefs amid venture funding recovery The Global Legal Post Thu, 11 Dec 2025 08:00:00 GMT
• once public, now private, gamida cell scores 2nd fda nod for stem cell therapy omisirge Fierce Pharma Tue, 09 Dec 2025 08:00:00 GMT
• Gene therapy in the real world: High priced, a long process and still relatively few patients | ASH 2025 Managed Healthcare Executive Sat, 06 Dec 2025 08:00:00 GMT
• genetix participates in the american society of hematology’s (ash) exclusive press program & shares recent patient experience data... Business Wire Sat, 06 Dec 2025 08:00:00 GMT
• stem cell therapy market is expected to reach us$ 45.69 billion openPR.com Wed, 03 Dec 2025 09:27:00 GMT
• will bluebird bio inc. stock pay special dividends - portfolio value summary & smart money movement tracker moha.gov.vn Fri, 28 Nov 2025 04:38:10 GMT
• viral vectors based gene therapy for non-human primates market openPR.com Thu, 27 Nov 2025 06:57:01 GMT
• cell and gene therapy patient access and reimbursement market openPR.com Thu, 27 Nov 2025 06:29:47 GMT
• as cgt struggles to scale, fda’s new designation could smooth post-approval pivots BioSpace Tue, 25 Nov 2025 08:00:00 GMT
• fda grants priority review for bluebird bio’s β-thalassemia gene therapy geneonline.com Sat, 22 Nov 2025 08:00:00 GMT
• bluebird bio announces 1-for-20 reverse stock split; shares tumble MSN Sat, 22 Nov 2025 05:09:58 GMT
• thalassemia market growth in future scope 2025-2032 |bluebird openPR.com Fri, 21 Nov 2025 09:50:47 GMT
• using data models to predict bluebird bio inc. stock movement - july 2025 closing moves & target return focused stock picks newser.com Thu, 20 Nov 2025 09:57:42 GMT
• can bluebird bio inc. stock reach $100 price target - 2025 trade ideas & weekly top performers watchlists newser.com Wed, 19 Nov 2025 22:55:03 GMT
• is bluebird bio inc. stock safe for conservative investors - 2025 bull vs bear & daily market momentum tracking newser.com Wed, 19 Nov 2025 21:52:34 GMT
• what wall street predicts for bluebird bio inc. stock price - market movers & community driven trade alerts newser.com Wed, 19 Nov 2025 21:45:55 GMT
• using data models to predict bluebird bio inc. stock movement - weekly trade review & daily oversold stock bounce ideas newser.com Wed, 19 Nov 2025 21:11:54 GMT
• is bluebird bio inc. reversing from oversold territory - market risk analysis & real-time volume trigger notifications newser.com Wed, 19 Nov 2025 20:54:22 GMT
• advanced therapies usa 2025: the current u.s. payer landscape NAVLIN DAILY Wed, 19 Nov 2025 18:11:21 GMT
• price action breakdown for bluebird bio inc. - july 2025 breakouts & precise trade entry recommendations newser.com Wed, 19 Nov 2025 16:43:28 GMT
• 31 mass. companies are on deloitte's north america technology fast 500 list The Business Journals Wed, 19 Nov 2025 08:00:00 GMT
• does bluebird bio inc. qualify in momentum factor screening - july 2025 movers & ai optimized trade strategies newser.com Wed, 19 Nov 2025 06:20:45 GMT
• how bluebird bio inc. stock trades during market volatility - 2025 key highlights & safe entry zone tips newser.com Wed, 19 Nov 2025 02:01:59 GMT
• can bluebird bio inc. stock reach $100 price target - july 2025 weekly recap & technical buy zone confirmations newser.com Tue, 18 Nov 2025 11:23:42 GMT
• what fibonacci levels say about bluebird bio inc. rebound - market sentiment review & weekly high conviction trade ideas newser.com Mon, 17 Nov 2025 02:59:21 GMT
• what sentiment indicators say about bluebird bio inc. stock - market movers & free real-time volume trigger notifications newser.com Sun, 16 Nov 2025 21:27:08 GMT
• what fibonacci levels say about bluebird bio inc. rebound - weekly profit recap & verified technical trade signals newser.com Sun, 16 Nov 2025 20:17:28 GMT
• is bluebird bio inc. stock safe for conservative investors - earnings recap report & fast gaining stock reports newser.com Sun, 16 Nov 2025 14:26:57 GMT
• is bluebird bio inc. reversing from oversold territory - 2025 volatility report & long-term growth stock strategies newser.com Sun, 16 Nov 2025 13:57:54 GMT
• why bluebird bio inc. stock could benefit from ai revolution - portfolio value report & weekly hot stock watchlists newser.com Sun, 16 Nov 2025 07:41:36 GMT
• using data models to predict bluebird bio inc. stock movement - quarterly portfolio report & growth focused entry reports newser.com Sun, 16 Nov 2025 07:30:21 GMT
• can bluebird bio inc. stock reach $100 price target - swing trade & expert verified stock movement alerts newser.com Sun, 16 Nov 2025 00:15:05 GMT
• is bluebird bio inc. stock a contrarian buy - weekly risk summary & free accurate trade setup notifications newser.com Sat, 15 Nov 2025 22:11:32 GMT
• can bluebird bio inc. recover in the next quarter - dollar strength & low risk investment opportunities newser.com Sat, 15 Nov 2025 18:43:58 GMT
• what wall street predicts for bluebird bio inc. stock price - oil prices & reliable entry point trade alerts newser.com Sat, 15 Nov 2025 16:23:13 GMT
• why bluebird bio inc. stock could benefit from ai revolution - 2025 geopolitical influence & daily stock trend watchlist newser.com Sat, 15 Nov 2025 11:39:54 GMT
• is bluebird bio inc. stock a contrarian buy - market growth report & smart allocation stock tips newser.com Fri, 14 Nov 2025 19:34:52 GMT
• why bluebird bio inc. stock could benefit from ai revolution - trade analysis summary & technical confirmation trade alerts newser.com Fri, 14 Nov 2025 13:55:04 GMT
• beta thalassemia treatment market to witness massive growth by 2032| novartis, bluebird bio, and celgene openPR.com Fri, 14 Nov 2025 10:35:12 GMT
• using data models to predict bluebird bio inc. stock movement - 2025 dividend review & growth-oriented investment plans newser.com Fri, 14 Nov 2025 10:31:36 GMT
• 10 gene therapy companies with promising treatments to watch Labiotech.eu Fri, 14 Nov 2025 08:00:00 GMT
• what fibonacci levels say about bluebird bio inc. rebound - earnings growth report & consistent profit trading strategies newser.com Fri, 14 Nov 2025 06:49:22 GMT
• real time alert setup for bluebird bio inc. performance - insider selling & short-term swing trade alerts newser.com Fri, 14 Nov 2025 05:11:14 GMT
• is bluebird bio inc. reversing from oversold territory - 2025 momentum check & real-time market trend scan newser.com Fri, 14 Nov 2025 05:10:06 GMT
• analyzing bluebird bio inc. with multi timeframe charts - july 2025 decliners & stepwise swing trade plans newser.com Thu, 13 Nov 2025 23:06:14 GMT
• what fibonacci levels say about bluebird bio inc. rebound - weekly trade report & risk controlled swing alerts newser.com Thu, 13 Nov 2025 22:52:06 GMT
• is bluebird bio inc. reversing from oversold territory - 2025 short interest & consistent profit alerts newser.com Thu, 13 Nov 2025 06:18:47 GMT
• is bluebird bio inc. stock supported by strong fundamentals - trade entry report & safe entry trade signal reports newser.com Thu, 13 Nov 2025 04:47:02 GMT
• is bluebird bio inc. stock a contrarian buy - 2025 trading volume trends & daily growth stock investment tips newser.com Thu, 13 Nov 2025 04:42:30 GMT
• what’s next for bluebird bio inc. stock price - 2025 price targets & safe entry point identification newser.com Thu, 13 Nov 2025 04:28:09 GMT
• is bluebird bio inc. reversing from oversold territory - portfolio return report & low drawdown trading techniques newser.com Wed, 12 Nov 2025 11:06:02 GMT
• what sentiment indicators say about bluebird bio inc. stock - 2025 endofyear setup & long hold capital preservation tips newser.com Wed, 12 Nov 2025 07:52:36 GMT
• using data models to predict bluebird bio inc. stock movement - quarterly trade summary & daily price action insights newser.com Wed, 12 Nov 2025 07:29:39 GMT
• analyzing bluebird bio inc. with multi timeframe charts - take profit & growth focused stock pick reports newser.com Wed, 12 Nov 2025 02:10:46 GMT
bluebird bio, Inc(NASDAQ:BLUE) 
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases and cancer. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent -thalassemia; Len...
Website: http://www.bluebirdbio.com
Founded: 1992
Full Time Employees: 1,171
Sector: Healthcare
Industry: Biotechnology